What is William Blair’s Forecast for TARS Q1 Earnings?
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) – Equities researchers at William Blair issued their Q1 2026 earnings per share estimates for shares of Tarsus Pharmaceuticals in a note issued to investors on Tuesday, February 25th. William Blair analyst L. Hanbury-Brown expects that the company will post earnings per share of ($0.06) for the quarter. […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) – Equities researchers at William Blair issued their Q1 2026 earnings per share estimates for shares of Tarsus Pharmaceuticals in a note issued to investors on Tuesday, February 25th. William Blair analyst L. Hanbury-Brown expects that the company will post earnings per share of ($0.06) for the quarter. […]
